47 results
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
1 Apr 24
Regulation FD Disclosure
8:00am
patent portfolio by filing for patent protection on new developments
Experienced Leadership Team Proven drug development and commercialization
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
-Threatening aneurysmal Subarachnoid Hemorrhage (aSAH)
oW. Taylor Kimberly, MD, PhD (Massachusetts General Hospital) joined Acasti leadership to discuss … formulation of nimodipine as an intravenous infusion and an alternative to the current standard of care. Acasti leadership also provided insight
8-K
EX-99.1
13og mw600xpi8pyax
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am
424B3
byj fhscfqz3mcq3
15 Jul 21
Prospectus supplement
4:45pm
S-4
r1qnrh
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-99.2
n662vrgd7xf
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-99.2
nr8555697kdfpr 7c1
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
gsaio0
17 Sep 20
Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
9:54pm
DEF 14A
6v5fivmnbz 1ri
9 Sep 20
Definitive proxy
4:00pm
PRE 14A
spz54mqu05 h514y07
10 Aug 20
Preliminary proxy
12:00am
10-K
5euso9rc5
29 Jun 20
Annual report
4:02pm
6-K
EX-99.1
se93h3ipwe9x8jmz
9 Sep 19
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
8:41am